Charles Russell Speechlys advises Harvest Minerals Ltd on its admission to AIM
Charles Russell Speechlys was pleased to act for Harvest Minerals Ltd on its admission to AIM on Monday 7 September 2015. Harvest is admitted to the Official List of ASX where the quotation of its securities commenced on 15 September 2010.
Harvest (or “the Group”) is a mining company with potash and phosphate exploration and development projects located in Brazil. The Group has three principal fertiliser projects – the Sergi Potash Project, the Capela Potash Project and the Arapua Fertilizer Project.
The Group is currently undertaking various exploration and development activities on all three projects and, subject to capital availability, intends to undertake further exploratory analysis and drilling activities, where appropriate, over the course of the coming year on the assets to further prove their potential.
The Charles Russell Speechlys’ team consisted of Partner Clive Hopewell, who led the deal, with the support of Senior Associate Paul Arathoon and Associate Amelly Kok.
Speaking of the transaction, Harvest commented: “We are delighted to be joining AIM, and we would like to thank the Charles Russell Speechlys team for extending such great support, hard work and dedication throughout the process”.
News & Insights
Government provides welcome clarity for EMI option holders who have been furloughed
The proposed amendments will provide some clarity and address concerns regarding the consequences of furloughing EMI option holders.
Charles Russell Speechlys advises Transense Technologies Plc on iTrack technology transaction with Bridgestone Corporation
Transense Technologies Plc, the provider of sensor systems for the industrial, mining and transportation markets.
Charles Russell Speechlys advises Kreos and SVB on $70m private placement for AIM listed Mereo BioPharma Group plc
Mereo BioPharma is a clinical stage UK-based biopharmaceutical company listed on the AIM market of the LSE.